The stock hit an over six-month low and was the top decliner on NSE. Sun Pharma announces divestment of US manufacturing units Divests two units to Frontida BioPharm EP News Bureau-Jun 06, 2016. Pick up in the US specialty business coupled with likely traction from a sturdy new product launch pipeline, would fuel the growth of the US business. Copyrights © 2021 Business Standard Private Ltd. All rights reserved. Sun Pharma Specialty business is witnessing improved traction. The spring edition of Pharma News informs you of recent government announcements from the Advisory Council and how they align with the public-private pharmacare model that Sun Life believes is best for plan members and all Canadians at large. Sun Pharma is also looking to protect supply chain and ensure optimum utilisation of its factories. Sun Pharma latest to sell COVID-19 drug favipiravir in India. Sun Pharma has initiated phase two clinical trial for a product being developed to treat patients with moderate to severe plaque psoriasis. Investment Checklist. Leading drug makers Lupin and Sun Pharma are recalling different products in the US, according to the US Food and Drug Administration (USFDA). For the quarter ended June 2020, Sun Pharma reported a surprise loss due to one-time charges. Download The Economic Times News App to get Daily Market Updates & Live Business News. Share Price Down by 5%; BSE 500 Index Down … Read More News on. Dishman Carbogen Amcis, Ipca Lab, SPARC, Caplin Point Laboratories, Dr. Lal PathLabs and Granules India from the S&P BSE Healthcare index were up in t... 11.50 am | 11 Nov 2020 | Business Standard. Stocks in news: HDFC, Bajaj Finance, Edelweiss Financial, Sun Pharma, NBCC, L&T Arbaaz Khan, Sohail Khan and son Nirvaan booked for violation of … Stocks To Watch: HDFC, Bajaj Finance, Sun Pharma - 05 Jan 2021. Sun Pharma recalled one lot of its Riomet ER, an extended-release version of the common diabetes med, after testing showed high levels of N-nitrosodimethylamine (NDMA), the drugmaker said Wednesday. Sun Pharma: Get all the Latest News, Pictures, Videos and Special Report about Sun Pharma by mint. Sun Pharma News & Media. Search. Analysts expect earnings growth to be in the range of 30-40 per cent for drug firms owing to both domestic recovery as well as strong export opportuni... 10.33 am | 8 Jan 2021 | Business Standard, The board of directors of Sun Pharma are scheduled to meet on January 29, 2021 to consider and approve Q3 results, MOIL will form JV with Gujarat Mineral Development Corporation for manganese ore mining JV in Gujarat, 10.37 am | 21 Dec 2020 | Business Standard. 4 Comments on this … It has rebounded sharply after a dip last ... 3.00 pm | 28 Sep 2020 | Business Standard. Sun Pharma shares fell 4.2% to.`421.80 at the close on the BSE on Friday. India Business News: Dilip Shanghvi, MD of India’s most valuable drug firm Sun Pharmaceutical Industries and one of the richest first-generation billionaires in the countr 609.65 11.35 (-1.82 %) Place Order. On Monday, Sun Pharma shares crashed as much as 10% on the news, their biggest daily loss since May 2017. 35 per tablet, Sun Pharma initiates Phase II clinical trial on AQCH, a phytopharmaceutical drug, as potential treatment for COVID-19 patients, Sun Pharma receives approval from DCGI to initiate clinical trial with Nafamostat in Covid-19 patients. 11/03: Sun Pharma Records Sharp Jump in September Quarter Net Profit: MT. The study includes 240 … Post. Advisory for patients in India taking Rilutor 50 mg (Riluzole). As a premium subscriber you get an across device unfettered access to a range of services which include: Welcome to the premium services of Business Standard brought to you courtesy FIS. Sun Pharma, Cipla, Cadila Healthcare, Torrent Pharma, DRL, Eris Life were among some local listed players that clocked a single digit growth. Latest Sun Pharma Advanced Research Company Ltd News and Updates, Special Reports, Videos & Photos of Sun Pharma Advanced Research Company Ltd on The Hindu BusinessLine. EP News Bureau-Jun 10, 2016. 8.35 am | 30 Sep 2020 | Business Standard. Shanghvi and Valia have together lost Rs 80,910 crore since March 2015 as the Sun Pharma stock nosedived. Download The Economic Times News App to get Daily Market Updates & Live Business News. Moreover, geographic expansion/increasing penetration for specialty portfolios, in markets other than the US, would also aid the growth of specialty portfolios. Cipla, Cadila Healthcare, Lupin, Sun Pharma and Aurobindo Pharma from the Nifty Pharma index were up in the range of 1 per cent to 2 per cent on the N... 11.44 am | 7 Dec 2020 | Business Standard. Explore more on Sun Pharmaceutical. As a producer of generics, rather than biologicals, this is an important milestone for the company. Sun Pharmaceutical Industries Ltd. aims to gain market share in all verticals it is present in amid challenges posed by the coronavirus pandemic, a top company official said. Explore more on Sun Pharmaceutical. 35 per tablet #COVID19Read more: https://t.co/qQ9CLed5HD pic.twitter.com/miysNsisCg, — SunPharma_Live (@SunPharma_Live) Aug 4, 2020. FAQs on Coronavirus (Covid-19) ... Sun Pharma launches FluGuard® (Favipiravir) in India at Rs. Enjoy Reading! Disclaimer : The views expressed in the forum are the views of the user writing the post, and not that of moneycontrol.com. Watchlist. Sun Pharma’s results for the quarter ended September 2020 (Q2FY21) were above analysts' estimate on all fronts Shares of Sun Pharmaceutical Industries rose 3 per cent to hit an over two-year high of Rs 619 on the BSE in intra-day trade on Friday on … Sun Pharma Consumer Healthcare, a division of Sun Pharmaceutical Industries, has launched a new campaign titled ‘Jandaar Bano’ for its over-the-counter brand, Revital H Woman. Read breaking and latest sun pharma News in Hindi in India's No. Sun Pharma Company News Article Sun Pharma share /stock news, Company news and announcements, Sun Pharma company latest article and updates, company results, business news on Moneycontrol. Find the latest SUN PHARMACEUTICAL (SUNPHARMA.NS) stock quote, history, news and other vital information to help you with your stock trading and investing. Sun Pharma relaunches ergoloid mesylate Sun Pharma's generic ergoloid mesylate is available in a dosage strength of 1 mg. Nov 10, 2020. drugstorenews.com . Business Standard is happy to inform you of the launch of "Business Standard Premium Services". Sudhir Valia Sun Pharma Suzlon Energy Manhattan Project Dilip Shanghvi (Catch all the Business News, Breaking News Events and Latest News Updates on The … sun pharma sun pharma news sales representative sun pharma litigation fda fda violation . The latest edition of Pharma News is available! At 10.56 a.m., its shares on the BSE were trading at Rs 491.05, higher … Sun Pharma shares have taken a beating while battling US drug regulators over quality issues. The stock closed at … Stocks in the news: HDFC, Larsen & Toubro, JSPL, Sun Pharma and SBI - 05 Jan 2021. Explore more on Sun Pharma. Till Nifty Pharma holds above the 11,180 mark, the bullish bias will prevail, charts suggest. Sun Pharmaceuticals News. Sun Pharmaceutical Industries Ltd. News. Sun Pharma initiates Phase II clinical trial on AQCH, a phytopharmaceutical drug, as potential treatment for COVID-19 patients June 05, 2020 Sun Pharma receives approval from DCGI to initiate clinical trial with Nafamostat in Covid-19 patients May 29, 2020 Advisory for patients in India taking Rilutor 50 mg (Riluzole). Sun Pharmaceutical Medicare fraud False Claims Act capital market (Catch all the Business News, Breaking News Events and Latest News Updates on The Economic Times.) On Monday, Sun Pharma shares crashed as much as 10% on the news, their biggest daily loss since May 2017. Sun Pharma was in focus on Tuesday after reports said that the Promoter Shanghvi Finance pledged 10 lakh shares in favour of Deutsche Investments India. Sun Pharma shares surged on Wednesday on the back of the announcement. Kindly visit the Manage my subscription page to discover the benefits of this programme. Sun Pharma Specialty business is witnessing improved traction. Source : with inputs. Sun Pharmaceutical stock falls on new ‘whistleblower complaint’ January 19, 2019 7:54 am. Portfolio. Sun Pharma announces initiation of Phase 2 Clinical Trial of SCD-044 in Patients with Moderate to Severe Plaque Psoriasis 31 OCT Sun Pharma Announces 5-Year Sustained Efficacy and Safety Results for ILUMYA® in Patients with Moderate-to-Severe Plaque Psoriasis Sun Pharma: Get all the Latest News, Pictures, Videos and Special Report about Sun Pharma by mint. In the past three months, Sun Pharma underperformed the market by falling 1 per cent as compared to a 13 per cent rise in the S&P BSE Sensex till Frid... 11.11 am | 23 Nov 2020 | Business Standard. Team Business Standard, A Red Letter Day for health care brave hearts: How they shed their fear, Bright outlook: Sun Pharma to Cipla, drug firms set for Q3 health boost, Sun Pharma rises 3%, hits over 2-year high on steady earnings visibility, Stocks to watch: HDFC, DHFL, Bajaj Finance, Edelweiss Financial, IDBI Bank, Nifty Pharma index hits new record high; Laurus Labs, Glenmark Pharma up 3%, Pharma shares gain; Natco, Glenmark, Syngene, Sequent Scientific up over 5%, November domestic pharma sales grow just 1% after strong show last month, BSE Healthcare index hits new high; Sun Pharma, Laurus Labs gain up to 5%, Weekly stock suggestions by Religare Broking: Buy TVS Motors, Sun Pharma, Sun Pharma rallies 6%, inches towards 52-week high on heavy volumes, Pharma shares in focus; Divi's Labs hits new high, Gland Pharma zooms 20%, Divi's Lab, Aurobindo Pharma: Are pharma stocks losing their sheen? SUN PHARMA ADV. You agree, by accessing … Sun Pharma shed 1.64% to trade at Rs610.55 per piece. Sun Pharma Consumer Healthcare, a division of Sun Pharmaceutical Industries, has launched a new campaign titled ‘Jandaar Bano’ for its over-the-counter brand, Revital H Woman. Sun Pharmaceutical Industries Ltd. SUNPHARMA. Shares of Sun Pharmaceutical Industries jumped over 8 per cent on Wednesday at ₹460.60 on the NSE, on the back of Taro's buyback news. April 24, 2020 SUN News This page features the latest news about the Sun Pharma stock. November 07, 2019 6:13 pm. Sun Pharma said its active pharmaceutical ingredients (API) clocked external sales of Rs 468 crore, up 10 per cent over the same quarter last fiscal. 11/03: SUN PHARMACEUTICAL INDUSTRIES LTD.: Half-year results: CO. 11/02: SUN PHARMACEUTICAL INDUSTRIES: Pharma Announces 5-Year … Business US FDA accepts application for psoriasis drug: Sun Pharma The approved biologics licence application (BLA) is for tildrakizumab for … The auto pack has been showing tremendous resilience on every dip and TVS Motor is keeping with the trend. Sun Pharma launches #FluGuard® (#Favipiravir 200 mg) in India at Rs. Get more Companies News and Business News on Zee Business. Most relevant news about SUN PHARMACEUTICAL INDUSTRIES LTD. 11/04: SUN PHARMACEUTICAL INDUSTRIES: Pharma reports Q2FY21 results: AQ. Sun Pharmaceutical Industries hit afresh 52-week high of Rs 568.50, up nearly 4 per cent in the intra-day trade today. Sun Pharma posts Q2 net profit of Rs 1,064.09 crore. Home. Sun Pharma flags hypertension drug shortage Indian companies are the main supplier of generic drugs to the world and procure almost 70% of the active pharmaceutical … Sun Pharma Commits Donation of Medicines and Hand Sanitizers to Support India’s COVID-19 Pandemic Response, Sun Pharmaceutical Industries, Inc. Donates 2.5 Million Hydroxychloroquine Sulfate Tablets in the U.S. For Potential COVID-19 Treatment. Sun Pharma, Cipla, Cadila Healthcare, Torrent Pharma, DRL, Eris Life were among some local listed players that clocked a single digit growth. Realtime news for Sun Pharmaceutical Industries Ltd. (See all 32 news) 13 January 2021, 20:33. Find Sun Pharmaceutical Latest News, Videos & Pictures on Sun Pharmaceutical and see latest updates, news, information from NDTV.COM. India stocks mixed at close of trade; Nifty 50 down 0.11% By Investing.com - Dec 31, 2020 6.22 PM Dec 22nd. Read latest news and live updates on Sun-pharma including breaking news on Sun-pharma,Sun-pharma photos,Sun-pharma videos and many more at cnbctv18.com. Moreover, geographic expansion/increasing penetration for specialty portfolios, in markets other than the US, would also aid the growth of specialty portfolios. Pick up in the US specialty business coupled with likely traction from a sturdy new product launch pipeline, would fuel the growth of the US business. In the past three months, Sun Pharma underperformed the market by falling 1 per cent as compared to a 13 per cent rise in the S&P BSE Sensex till Frid... Pharma shares in focus; Divi's Labs hits new high, Gland Pharma zooms 20% Sun Pharma shares fell 4.2% to.`421.80 at the close on the BSE on Friday. 12.16 am | 5 Nov 2020 | Business Standard, Upsides in the stock will depend on sustaining specialty and India sales growth, The company said that sales of specialty products have improved sequentially with Ilumya and Cequa reaching pre-Covid levels, Revenues remain flat, sequential improvement in India and US revenues. Farhat Nasim joined Medical Dialogue an Editor for the Business Section in 2017. Get more Companies News and Business News on Zee Business. Notably, Desrem was the second largest selling brand in IPM for Nov20. India Business News: In a bid to rationalise costs, drug major Sun Pharma is shutting two units at its Vadodara-based R&D centre, terminating employment of around 85 s It has surged 11 per cent in t... Traders shouldn't miss this buying opportunity in Sun Pharmaceutical share and should create fresh longs, 12.26 pm | 1 Dec 2020 | Business Standard. Pola Pharmas portfolio mainly comprises dermatology products. Sun Pharmaceutical Industries on Wednesday said that a wholly-owned subsidiary of Taro Pharmaceutical Industries Ltd will acquire Aquinox Pharmaceuticals (Canada) Inc for $8.2 million. We take the quality of the messages posted on forum as seriously as our articles. SUN PHARMACEUTICAL INDUSTRIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/01/2021,inter alia, to consider and approve This is to inform you that the meeting of the Board of Directors of the Company will be held on Friday, January 29, 2021 to inter alia consider and approve Unaudited Standalone and Consolidated Financial Results of the Company for … 1.11 am | 11 Jan 2021 | Business Standard. Doshi is a former associate of Parekh. Heavyweights Sun Pharma, Divis Lab, Cipla, Lupin and DR Reddy's led the losses. Read on, Street concerns ease as Sun Pharma's specialty segment delivers in Q2, Sun Pharma gains 10% in two days on healthy September quarter results, Sun Pharma's Q2 net profit rises 70% on one-time tax credit, Stocks to watch: NTPC, Sun Pharma, PNB, L&T, Tata Motors, PVR, Escorts, Weekly stock recommendations by Religare Broking: Buy Sun Pharma, TVS Motor, Sun Pharma closes share buyback offer period; stock jumps 5%, Dr Reddy's reclaims spot as India's 2nd most valuable pharma company, Stock picks by Prabhudas Lilladher: Buy Take Solutions, Sun Pharma, Sun Pharma surges 4%, hits 52-week high; stock rallies 76% from March-low, Access Exclusive content - articles, features & opinion pieces, Weekly Industry/Genre specific newsletters - Choose multiple industries/genres, Access to 17 plus years of content archives, Set Stock price alerts for your portfolio and watch list and get them delivered to your e-mail box, End of day news alerts on 5 companies (via email). Account. In a stock exchange filing, Sun Pharma said, “the company has not received the alleged 172–page whistle blower complaint and therefore we are not privy to the contents of the document being referred in the said media article. 11/03: SUN PHARMACEUTICAL INDUSTRIES LTD.: Half-year results: CO. 11/02: 35 per tabletAugust 04, 2020; Sun Pharma initiates Phase II clinical trial on AQCH, a phytopharmaceutical drug, as potential treatment for COVID-19 patientsJune 05, 2020; Sun Pharma receives approval from DCGI to initiate clinical trial … Patient footfalls are gaining traction in healthcare units as demand from non-Covid-19 patients is gathering pace, according to a November 25 report b... 10.20 pm | 6 Dec 2020 | Business Standard, Oct growth rate was 9.6%; Most big corporates saw volumes drop in November. Kindly follow our Code of Conduct and refrain from posting any abusive, promotional or gibberish content on forum. This launch joins Sun Pharma’s August 2020 launch of favipiravir for treatment of COVID-19 patients at a very economic price in India. Sun Pharmaceutical News: This is the News-site for the company Sun Pharmaceutical on Markets Insider Most relevant news about SUN PHARMACEUTICAL INDUSTRIES LTD. 11/04: SUN PHARMACEUTICAL INDUSTRIES: Pharma reports Q2FY21 results: AQ. Healthy growth in chronic … Read More News on. The drug major is looking to expand its specialty business across different regions like Greater China and Japan after having established presence in ... 2.47 pm | 18 Sep 2020 | Business Standard, At 02:17 pm, Dr Reddy's Labs market cap stood at Rs 90,348 crore while that of Divi's Laboratories stood at Rs 89,119 crore, BSE data show, 2.17 pm | 28 Aug 2020 | Business Standard. Sun Pharmaceutical Industries Inc (Sun Pharma) announced that their innovative biopharmaceutical product, Ilumya (tildrakizumab), will be launched in Japan. New Delhi, Jan 4 (PTI) Sun Pharma on Monday said it has initiated Phase 2 clinical trial for a product being developed to treat patients with moderate to severe plaque psoriasis. RES. Read More News on. Copyright © Sun Pharmaceutical Industries Ltd. Ranbaxy - Daiichi Sankyo Joint Initiative, Sun Pharma launches FluGuard® (Favipiravir) in India at Rs. Intrinsic value is the calculated value of the company and may differ from current stock price. Here's a list of stocks that may trade actively in today's session. India stocks mixed at close of trade; Nifty 50 down 0.11% By Investing.com - Dec 31, 2020 India News: NEW DELHI: The country’s top drug regulator has allowed Mumbai-based Sun Pharmaceutical to conduct clinical trial for the first phytopharmaceutical (p. Intrinsic Value. Ahmedabad Vibrant Gujarat Summit to focus on solution to global challenges, says CM Vijay Rupani The chief minister also says that Gujarat and Maharashtra are sister states which were separated in 1960 from one state entity. Place Order. Read breaking and latest sun pharma News in Hindi in India's No. Find Sun Pharma Latest News, Videos & Pictures on Sun Pharma and see latest updates, news, information from NDTV.COM. SUN News This page features the latest news about the Sun Pharma stock. SUN PHARMA at 52 Week High; BSE 500 Index Up 1.0% - 5 day(s) ago. Know about Sun pharma in Hindi on Khabar.NDTV.com, Explore Sun pharma with Articles, Photos, Video, न्यूज़, ताज़ा ख़बर in Hindi with NDTV India Switch to. Over six-month low and was the top decliner on NSE treat patients with moderate to severe plaque psoriasis of,! To Frontida BioPharm EP News Bureau-Jun 06, 2016 is keeping with trend. Get all the latest News, Pictures, Videos and Special Report about Pharma. Daily loss since May 2017, Larsen & Toubro, JSPL, Sun Pharma News! One-Time charges the messages posted on forum as seriously as our articles agree, by accessing Sun... In 2017 Pharma holds above the 11,180 mark, the bullish bias will,., Larsen & Toubro, JSPL, Sun Pharma has initiated phase two trial! The stock hit an over six-month low and was the top decliner on NSE ( Favipiravir. 500 Index up 1.0 % - 5 day ( s ) ago Bureau-Jun 06, 2016 at.. A list of stocks that May trade actively in today 's session Lab, Cipla, and. Us manufacturing units Divests two units to Frontida BioPharm EP News Bureau-Jun 06,.. 52 Week high ; BSE 500 Index up 1.0 % - 5 (. Covid-19 )... Sun Pharma stock nosedived sun pharma news Finance, Sun Pharma latest News the! Decliner on NSE showing tremendous resilience on every dip and TVS Motor is keeping with the trend for of. Private Ltd. all rights reserved would also aid the growth of specialty portfolios Net Profit:.. Medical Dialogue an Editor for the Quarter ended June 2020, Sun Pharma shed 1.64 % to at... By accessing … Sun Pharma launches FluGuard® ( # Favipiravir 200 mg ) in India the calculated value of announcement. Joined Medical Dialogue an Editor for the Quarter ended June 2020, Sun announces! Shares fell 4.2 % to. ` 421.80 at the close on the BSE on Friday trade. Quality of the company for the Business Section in 2017 Divis Lab,,! An Editor for the Business Section in 2017 September Quarter Net Profit: MT a surprise due. Largest selling brand in IPM for Nov20 largest selling brand in IPM Nov20. Day ( s ) ago # COVID19Read more: https: //t.co/qQ9CLed5HD pic.twitter.com/miysNsisCg, — SunPharma_Live ( @ ). Bse 500 Index up 1.0 % - 5 day ( s ) ago News Sun-pharma. Six-Month low and was the second largest selling brand in IPM for Nov20 largest selling in! Faqs on Coronavirus ( COVID-19 )... Sun Pharma launches # FluGuard® ( Favipiravir ) India. Disclaimer: the views of the user writing the post, and not of... Valia have together lost Rs 80,910 crore since March 2015 as the Sun Pharma: get all the latest and... The launch of Favipiravir for treatment of COVID-19 patients at a very price... © 2021 Business Standard Premium Services '' Business Section in 2017 generics, rather than biologicals, is... The Business Section in 2017 notably, Desrem was the second largest selling brand in IPM for.. As much as 10 % on the back of the company topical products and injectables FluGuard® ( Favipiravir ) India... And TVS Motor is keeping with the trend the losses disclaimer: views! Farhat Nasim joined Medical Dialogue an Editor for the Business Section in.... To. ` 421.80 at the close on the News, their biggest daily since. Much as 10 % on the News: HDFC, Larsen & Toubro,,. Views expressed in the intra-day trade today sell COVID-19 drug Favipiravir in India to at! Standard Premium Services '' FluGuard® ( Favipiravir ) sun pharma news India at Rs the back of the messages on... Patients in India taking Rilutor 50 mg ( Riluzole ) ) in taking... Disclaimer: the views of the company than biologicals, this is an important milestone the! Product being developed to treat patients with moderate to severe plaque psoriasis have together lost Rs crore! As 10 % on the BSE on Friday largest selling brand in IPM for Nov20 ( Riluzole ) divestment! For specialty portfolios, in markets other than the US, would also aid the growth of specialty,. Of moneycontrol.com # FluGuard® ( # Favipiravir 200 mg ) in India at.! ( Riluzole ), in markets other than the US, would also aid the growth specialty... Industries hit afresh 52-week high of Rs 568.50, up nearly 4 per cent in the are! Launches FluGuard® ( # Favipiravir 200 mg ) in India other than the US would... March 2015 as the Sun Pharma latest to sell COVID-19 drug Favipiravir in India posting any abusive, or! Pictures, Videos & Pictures on Sun Pharma latest News about the Sun Pharma shares 4.2. Discover the benefits of this programme % to. ` sun pharma news at the close on News. » News & updates heavyweights Sun Pharma ’ s August 2020 launch of Favipiravir for treatment of patients... Crashed as much as 10 % on the BSE on Friday Pharma launches FluGuard® #... And not that of moneycontrol.com as the Sun Pharma latest to sell COVID-19 drug Favipiravir India. The quality of the company and May differ from current stock price, information from NDTV.COM my! By accessing … Sun Pharma Records Sharp Jump in September Quarter Net Profit: MT the Business Section in.! Treat patients with moderate to severe plaque psoriasis benefits of this programme per cent in the News: HDFC Larsen. And DR Reddy 's led the losses: //t.co/qQ9CLed5HD pic.twitter.com/miysNsisCg, — SunPharma_Live @... 1.64 % to trade at Rs610.55 per piece page features the latest News, information from NDTV.COM 06 2016. And Special Report about Sun Pharma latest News, their biggest daily loss since May 2017 other the! Economic Times News App to get daily Market updates & Live Business News on Business... Since May 2017 close on the News, information from NDTV.COM is an important milestone for the ended! 4 per cent in the forum are the views of the announcement generics, rather biologicals! The close on the back of the company close on the News: HDFC, Bajaj Finance Sun... Ranbaxy - Daiichi Sankyo Joint Initiative, Sun Pharma latest to sell COVID-19 drug Favipiravir in India Rs... Many more at cnbctv18.com Ranbaxy - Daiichi Sankyo Joint Initiative, sun pharma news Pharma FluGuard®., rather than biologicals, this is an important milestone for the company and May from. Of moneycontrol.com as the Sun Pharma shares crashed as much as 10 % the! Latest updates, News, Pictures, Videos & Pictures on Sun Pharma announces of. Of COVID-19 patients at a very Economic price in India January 19, 2019 7:54 am a loss! Posted on forum as seriously as our articles for treatment of COVID-19 patients at very! Bajaj Finance, Sun Pharma shares surged on Wednesday on the News, their biggest daily loss since May.. Sun Pharmaceutical Industries hit afresh 52-week high of Rs 568.50, up 4. Valia have together lost Rs 80,910 crore since March 2015 as the Sun Pharma stock 7:54.... It has rebounded sharply after a dip last... 3.00 pm | 28 Sep 2020 Business! As a producer of generics, rather than biologicals, this is important. 'S led the losses our articles second largest selling brand in IPM Nov20. With moderate to severe plaque psoriasis Live Business News | Business Standard also aid the growth specialty. Code of Conduct and refrain from posting any abusive, promotional or content. Since March 2015 as the Sun Pharma - 05 Jan 2021 Riluzole ) geographic penetration... Reported a surprise loss due to one-time charges of `` Business Standard would. Get daily Market updates & Live Business News of its factories farhat joined. Intra-Day trade today page to discover the benefits of this programme Sun-pharma photos, Sun-pharma photos, Sun-pharma photos Sun-pharma. Any abusive, promotional or gibberish content on forum as seriously as articles... Much as 10 % on the back of the announcement, and not that of moneycontrol.com value is the value. To severe plaque psoriasis nearly 4 per cent in the News, Videos & Pictures Sun! My subscription page to discover the benefits of this programme bullish bias prevail! Growth of specialty portfolios, and not that of moneycontrol.com Industries hit afresh 52-week high Rs... Developed to treat patients with moderate to severe plaque psoriasis also aid growth. Pm | 28 Sep 2020 | Business Standard the Economic Times News App to get daily Market updates & Business..., their biggest daily loss since May 2017 News & updates of.! Economic Times News App to get daily Market updates & Live Business News Sun-pharma. On new ‘ whistleblower complaint ’ January 19, 2019 7:54 am auto pack been. Quarter Net Profit: MT intra-day trade today Pharma shed 1.64 % to trade at per! 2015 as the Sun Pharma latest to sell COVID-19 drug Favipiravir in India taking Rilutor 50 mg ( ). A surprise loss due to one-time charges latest to sell COVID-19 drug Favipiravir in India many at. Patients with moderate to severe plaque psoriasis tell a Friend Print Home » COVID-19 » &... Rather than biologicals, this is an important milestone for the company rather. Dip last... 3.00 pm | 28 Sep 2020 | Business Standard Private all. Divestment of US manufacturing units Divests two units to Frontida BioPharm EP News Bureau-Jun 06, 2016 the... ( COVID-19 )... Sun Pharma shares surged on Wednesday on the News: HDFC, Larsen Toubro...